Lepu Medical Tech Beijing (300003) - Net Assets
Based on the latest financial reports, Lepu Medical Tech Beijing (300003) has net assets worth CN¥17.75 Billion CNY (≈ $2.60 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥25.61 Billion ≈ $3.75 Billion USD) and total liabilities (CN¥7.87 Billion ≈ $1.15 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 300003 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥17.75 Billion |
| % of Total Assets | 69.29% |
| Annual Growth Rate | 31.84% |
| 5-Year Change | 58.87% |
| 10-Year Change | 213.57% |
| Growth Volatility | 70.66 |
Lepu Medical Tech Beijing - Net Assets Trend (2006–2024)
This chart illustrates how Lepu Medical Tech Beijing's net assets have evolved over time, based on quarterly financial data. Also explore 300003 total assets for the complete picture of this company's asset base.
Annual Net Assets for Lepu Medical Tech Beijing (2006–2024)
The table below shows the annual net assets of Lepu Medical Tech Beijing from 2006 to 2024. For live valuation and market cap data, see 300003 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥16.74 Billion ≈ $2.45 Billion |
-4.33% |
| 2023-12-31 | CN¥17.50 Billion ≈ $2.56 Billion |
+6.88% |
| 2022-12-31 | CN¥16.37 Billion ≈ $2.40 Billion |
+33.39% |
| 2021-12-31 | CN¥12.27 Billion ≈ $1.80 Billion |
+16.48% |
| 2020-12-31 | CN¥10.54 Billion ≈ $1.54 Billion |
+31.64% |
| 2019-12-31 | CN¥8.00 Billion ≈ $1.17 Billion |
+21.73% |
| 2018-12-31 | CN¥6.58 Billion ≈ $962.28 Million |
-6.42% |
| 2017-12-31 | CN¥7.03 Billion ≈ $1.03 Billion |
+16.86% |
| 2016-12-31 | CN¥6.01 Billion ≈ $879.94 Million |
+12.64% |
| 2015-12-31 | CN¥5.34 Billion ≈ $781.21 Million |
+62.14% |
| 2014-12-31 | CN¥3.29 Billion ≈ $481.81 Million |
+13.76% |
| 2013-12-31 | CN¥2.89 Billion ≈ $423.55 Million |
+10.54% |
| 2012-12-31 | CN¥2.62 Billion ≈ $383.16 Million |
+11.83% |
| 2011-12-31 | CN¥2.34 Billion ≈ $342.64 Million |
+13.32% |
| 2010-12-31 | CN¥2.07 Billion ≈ $302.36 Million |
+17.67% |
| 2009-12-31 | CN¥1.76 Billion ≈ $256.95 Million |
+243.48% |
| 2008-12-31 | CN¥511.23 Million ≈ $74.81 Million |
+33.17% |
| 2007-12-31 | CN¥383.88 Million ≈ $56.17 Million |
+232.33% |
| 2006-12-31 | CN¥115.51 Million ≈ $16.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Lepu Medical Tech Beijing's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 17220.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥9.43 Billion | 62.06% |
| Common Stock | CN¥1.88 Billion | 12.37% |
| Other Comprehensive Income | CN¥1.72 Billion | 11.33% |
| Other Components | CN¥2.16 Billion | 14.24% |
| Total Equity | CN¥15.20 Billion | 100.00% |
Lepu Medical Tech Beijing Competitors by Market Cap
The table below lists competitors of Lepu Medical Tech Beijing ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tanger Factory Outlet Centers Inc
NYSE:SKT
|
$3.87 Billion |
|
Wuchan Zhongda Group Co Ltd
SHG:600704
|
$3.87 Billion |
|
Abercrombie & Fitch Company
NYSE:ANF
|
$3.88 Billion |
|
Shanghai AtHub Co Ltd
SHG:603881
|
$3.88 Billion |
|
Dalmia Bharat Limited
NSE:DALBHARAT
|
$3.87 Billion |
|
Bill Com Holdings Inc
NYSE:BILL
|
$3.87 Billion |
|
CSSC Offshore & Marine Engineering Group Co Ltd
SHG:600685
|
$3.86 Billion |
|
Industrias CH S. A. B. de C. V
MX:ICHB
|
$3.86 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lepu Medical Tech Beijing's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 15,976,101,963 to 15,201,421,378, a change of -774,680,585 (-4.8%).
- Net income of 246,937,718 contributed positively to equity growth.
- Dividend payments of 990,894,972 reduced retained earnings.
- Share repurchases of 177,427,414 reduced equity.
- Other comprehensive income increased equity by 1,721,763,506.
- Other factors decreased equity by 1,575,059,423.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥246.94 Million | +1.62% |
| Dividends Paid | CN¥990.89 Million | -6.52% |
| Share Repurchases | CN¥177.43 Million | -1.17% |
| Other Comprehensive Income | CN¥1.72 Billion | +11.33% |
| Other Changes | CN¥-1.58 Billion | -10.36% |
| Total Change | CN¥- | -4.85% |
Book Value vs Market Value Analysis
This analysis compares Lepu Medical Tech Beijing's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.74x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 60.46x to 1.74x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | CN¥0.24 | CN¥14.35 | x |
| 2007-12-31 | CN¥0.32 | CN¥14.35 | x |
| 2008-12-31 | CN¥0.35 | CN¥14.35 | x |
| 2009-12-31 | CN¥1.17 | CN¥14.35 | x |
| 2010-12-31 | CN¥1.27 | CN¥14.35 | x |
| 2011-12-31 | CN¥1.44 | CN¥14.35 | x |
| 2012-12-31 | CN¥1.61 | CN¥14.35 | x |
| 2013-12-31 | CN¥1.74 | CN¥14.35 | x |
| 2014-12-31 | CN¥1.94 | CN¥14.35 | x |
| 2015-12-31 | CN¥2.96 | CN¥14.35 | x |
| 2016-12-31 | CN¥3.19 | CN¥14.35 | x |
| 2017-12-31 | CN¥3.61 | CN¥14.35 | x |
| 2018-12-31 | CN¥3.56 | CN¥14.35 | x |
| 2019-12-31 | CN¥4.23 | CN¥14.35 | x |
| 2020-12-31 | CN¥5.56 | CN¥14.35 | x |
| 2021-12-31 | CN¥6.35 | CN¥14.35 | x |
| 2022-12-31 | CN¥8.34 | CN¥14.35 | x |
| 2023-12-31 | CN¥8.60 | CN¥14.35 | x |
| 2024-12-31 | CN¥8.22 | CN¥14.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lepu Medical Tech Beijing utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.62%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.05%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 1.62x
- Recent ROE (1.62%) is below the historical average (19.43%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 55.06% | 36.27% | 0.99x | 1.54x | CN¥52.05 Million |
| 2007 | 39.00% | 50.08% | 0.66x | 1.18x | CN¥111.34 Million |
| 2008 | 39.92% | 51.12% | 0.65x | 1.21x | CN¥150.93 Million |
| 2009 | 16.71% | 51.70% | 0.30x | 1.06x | CN¥117.31 Million |
| 2010 | 19.87% | 53.30% | 0.35x | 1.08x | CN¥203.85 Million |
| 2011 | 20.21% | 52.02% | 0.37x | 1.04x | CN¥239.00 Million |
| 2012 | 15.44% | 39.70% | 0.37x | 1.05x | CN¥142.06 Million |
| 2013 | 12.79% | 27.75% | 0.42x | 1.11x | CN¥78.89 Million |
| 2014 | 13.47% | 25.36% | 0.44x | 1.22x | CN¥108.94 Million |
| 2015 | 10.84% | 18.81% | 0.36x | 1.61x | CN¥40.20 Million |
| 2016 | 12.27% | 19.59% | 0.37x | 1.72x | CN¥125.82 Million |
| 2017 | 13.98% | 19.81% | 0.35x | 1.99x | CN¥256.12 Million |
| 2018 | 19.19% | 19.17% | 0.42x | 2.38x | CN¥583.73 Million |
| 2019 | 23.06% | 22.13% | 0.49x | 2.13x | CN¥977.03 Million |
| 2020 | 18.25% | 22.42% | 0.44x | 1.85x | CN¥814.65 Million |
| 2021 | 14.98% | 16.13% | 0.51x | 1.80x | CN¥571.94 Million |
| 2022 | 14.55% | 20.77% | 0.43x | 1.62x | CN¥689.06 Million |
| 2023 | 7.88% | 15.77% | 0.32x | 1.57x | CN¥-339.41 Million |
| 2024 | 1.62% | 4.05% | 0.25x | 1.62x | CN¥-1.27 Billion |
Industry Comparison
This section compares Lepu Medical Tech Beijing's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,213,703,927
- Average return on equity (ROE) among peers: 12.88%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lepu Medical Tech Beijing (300003) | CN¥17.75 Billion | 55.06% | 0.44x | $3.87 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $486.48 Million | 24.26% | 0.26x | $449.34 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $405.69 Million | 15.24% | 0.11x | $4.30 Billion |
| Double Medical Technology Inc (002901) | $3.16 Billion | 1.87% | 0.47x | $2.63 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $49.59 Million | 43.44% | 0.23x | $577.41 Million |
| INKON Life Technology Co Ltd (300143) | $116.90 Million | 17.41% | 0.92x | $1.23 Billion |
| Edan Instruments Inc (300206) | $1.22 Billion | 8.49% | 0.19x | $1.26 Billion |
| Guangdong Biolight Meditech Co Ltd (300246) | $1.39 Billion | -4.69% | 0.82x | $685.28 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.45 Billion | 0.44% | 0.18x | $534.16 Million |
| Sinocare Inc (300298) | $2.65 Billion | 9.46% | 0.24x | $1.36 Billion |
About Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd. develops, manufactures, and distributes medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters, Angiocide peripheral cutting balloons, and PeakSheath disposable artery sheath; and cardiovascular products, such as coronary stents and balloons, catheters, guide … Read more